Non-peptide αvβ3 antagonists. Part 3: Identification of potent RGD mimetics incorporating novel β-amino acids as aspartic acid replacements by COLEMAN, Paul J, BRASHEAR, Karen M, RODAN, Gideon A, LEU, Chih-Tai, PRUEKSARITANONT, Thomayant, FERNANDEZ-METZLER, Carmen, MA, Bennett, LIBBY, Laura A, MERKLE, Kara M, STUMP, Gary L, WALLACE, Audrey A, LYNCH, Joseph J, HUNT, Cecilia A, LYNCH, Robert, DUGGAN, Mark E, HOFFMAN, William F, HUTCHINSON, John H, BRESLIN, Michael J, MCVEAN, Carol A, ASKEW, Ben C, HARTMAN, George D, RODAN, Sevgi B

Get full text

Nonpeptide αvβ3 Antagonists. Part 11:  Discovery and Preclinical Evaluation of Potent αvβ3 Antagonists for the Prevention and Treatment of Osteoporosis by Coleman, Paul J, Brashear, Karen M, Askew, Ben C, Hutchinson, John H, McVean, Carol A, Duong, Le T, Feuston, Bradley P, Fernandez-Metzler, Carmen, Gentile, Michael A, Hartman, George D, Kimmel, Donald B, Leu, Chih-Tai, Lipfert, Lorraine, Merkle, Kara, Pennypacker, Brenda, Prueksaritanont, Thomayant, Rodan, Gideon A, Wesolowski, Gregg A, Rodan, Sevgi B, Duggan, Mark E

Get full text

Non-Peptide α vβ 3 antagonists. Part 3: Identification of potent RGD mimetics incorporating novel β-Amino acids as aspartic acid replacements by Coleman, Paul J, Brashear, Karen M, Hunt, Cecilia A, Hoffman, William F, Hutchinson, John H, Breslin, Michael J, McVean, Carol A, Askew, Ben C, Hartman, George D, Rodan, Sevgi B, Rodan, Gideon A, Leu, Chih-Tai, Prueksaritanont, Thomayant, Fernandez-Metzler, Carmen, Ma, Bennett, Libby, Laura A, Merkle, Kara M, Stump, Gary L, Wallace, Audrey A, Lynch, Joseph J, Lynch, Robert, Duggan, Mark E

Get full text

Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis by Coleman, Paul J, Brashear, Karen M, Askew, Ben C, Hutchinson, John H, McVean, Carol A, Duong, Le T, Feuston, Bradley P, Fernandez-Metzler, Carmen, Gentile, Michael A, Hartman, George D, Kimmel, Donald B, Leu, Chih-Tai, Lipfert, Lorraine, Merkle, Kara, Pennypacker, Brenda, Prueksaritanont, Thomayant, Rodan, Gideon A, Wesolowski, Gregg A, Rodan, Sevgi B, Duggan, Mark E

Get full text

Nonpeptide α v β 3 Antagonists. Part 11:  Discovery and Preclinical Evaluation of Potent α v β 3 Antagonists for the Prevention and Treatment of Osteoporosis by Coleman, Paul J., Brashear, Karen M., Askew, Ben C., Hutchinson, John H., McVean, Carol A., Duong, Le T., Feuston, Bradley P., Fernandez-Metzler, Carmen, Gentile, Michael A., Hartman, George D., Kimmel, Donald B., Leu, Chih-Tai, Lipfert, Lorraine, Merkle, Kara, Pennypacker, Brenda, Prueksaritanont, Thomayant, Rodan, Gideon A., Wesolowski, Gregg A., Rodan, Sevgi B., Duggan, Mark E.

Get full text

Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements by Coleman, Paul J, Brashear, Karen M, Hunt, Cecilia A, Hoffman, William F, Hutchinson, John H, Breslin, Michael J, McVean, Carol A, Askew, Ben C, Hartman, George D, Rodan, Sevgi B, Rodan, Gideon A, Leu, Chih Tai, Prueksaritanont, Thomayant, Fernandez-Metzler, Carmen, Ma, Bennett, Libby, Laura A, Merkle, Kara M, Stump, Gary L, Wallace, Audrey A, Lynch, Joseph J, Lynch, Robert, Duggan, Mark E

Get full text

A map of human genome variation from population-scale sequencing by Abecasis, Gonçalo R, Altshuler, David, Auton, Adam, Brooks, Lisa D, Durbin, Richard M, Gibbs, Richard A, Hurles, Matt E, McVean, Gil A

Get full text

Implementation of a High-Resolution Liquid Chromatography–Mass Spectrometry Method in Quality Control Laboratories for Release and Stability Testing of a Commercial Antibody Produc... by Sokolowska, Izabela, Mo, Jingjie, Rahimi Pirkolachahi, Fatie, McVean, Carol, Meijer, Lars A. T, Switzar, Linda, Balog, Crina, Lewis, Michael J, Hu, Ping

Get full text